|
U.S. Microbics, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for U.S. Microbics, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
U.S. Microbics, Inc.. The Group's principal activities are to provide proprietary products and services for applications in the global bioremediation, wastewater treatment and regenerative agriculture markets. It facilitates and develops the deployment of environmental technologies through its two segments: USM Solutions and USM Capital. USM Solutions specializes in developing, manufacturing and selling engineered remediation solutions for clean up of toxic waste releases to soil and or groundwater and the bio-recycling of spent activated carbon filtration media. USM Capital is the financial services division of U.S. Microbics and provides an array of financial services for private and publicly traded companies. The services include management services and planning, becoming a publicly reporting or trading company, capital financing, aftermarket support, investor relations, corporate governance, administrative services and CEO training. It primarily operates in the domestic market.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
